calcitonin + PTH (Bone Medical)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namecalcitonin + PTH (Bone Medical)
Drug Alias Namecalcitonin + parathyroid hormone (Bone Medical)BN-004
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionParathyroid hormone replacementsParathyroid hormone receptor agonistsCalcitonin receptor agonists
TargetsCalcitonin receptorParathyroid hormone receptor
Therapy Area/IndicationsOsteoporosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryAustralia and New Zealand
CombinationsYes
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBotanix Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBotanix Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsOsteoporosis

Other Information

ATC CodeN/A
Related LinksN/A